PENPULIMAB
UNII IBS1BZ4E4I

Substance Identification & Data

This profile provides standardized clinical and technical data for Penpulimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) IBS1BZ4E4I.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2350298-92-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

IBS1BZ4E4I

CAS Registry Number

2350298-92-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PENPULIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

IBS1BZ4E4I

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C155879

National Cancer Institute reference terminology for clinical and research data.

INN ID

11497

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-165

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Penpulimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PENPULIMAB

PENPULIMAB-KCQX

Common Names & Synonyms

ANTI-PD-1 MONOCLONAL ANTIBODY AK105

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED CELL DEATH 1) (HUMAN-MUS MUSCULUS MONOCLONAL AK105 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AK105 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODY (PENPULIMAB)

PENPULIMAB [INN]

PENPULIMAB [USAN]

PENPULIMAB [WHO-DD]

PENPULIMAB KCQX [WHO-DD]